MDS 17th International Congress of Parkinson’s Disease and Movement Disorders

Sydney (PRWEB) June 07, 2013

The worlds leading experts in Parkinsons disease and Movement Disorders will present the latest research findings and state-of-the-art treatment options at The Movement Disorder Societys 17th International Congress of Parkinsons Disease and Movement Disorders in Sydney, June 16-20, 2013.

The 17th International Congress, held at the Sydney Convention and Exhibition Centre, will be attended by over 2,100 international physicians, researchers and other healthcare professionals. Attendees will be able to view over 1,300 scientific abstracts submitted by clinicians from around the world. The International Congress Scientific Program consists of Plenary, Parallel, and Video Sessions, as well as Skills Workshops, Teaching Courses, and Guided Poster Tours.

Registration Members of the media receive complimentary full-access registration to the Congress. For information on how to register, please contact Elizabeth Clausen at eclausen(at)movementdisorders(dot)org.

News Releases Read summaries of newsworthy research to be presented at the Congress.

-New findings on the lessebo effect in Parkinson's disease may be game-changer for study design

-Apomorphine represents possible therapeutic target to reduce Parkinson's disease dementia

-New MDS Study Groups bring researchers together to focus on MDS mission-driven initiatives

-New mouse model provides insight into human -synuclein accumulation in Parkinson's disease

-Increased risk of malignant melanoma in Parkinson's disease patients shows need for dermatologic screening

Read the rest here:
MDS 17th International Congress of Parkinson’s Disease and Movement Disorders